Can leptomeningeal enhancement be linked to multiple sclerosis?

Affiliations

¹ From the Department of Radiology & Nuclear Medicine (F.B.), VU University Medical Centre, Amsterdam, the Netherlands; and the Translational Neuroradiology Unit (D.S.R.), National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD. f.barkhof@vumc.nl.
² From the Department of Radiology & Nuclear Medicine (F.B.), VU University Medical Centre, Amsterdam, the Netherlands; and the Translational Neuroradiology Unit (D.S.R.), National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD.

Editorial

Frederik Barkhof et al. Neurology. 2015.

. 2015 Feb 24;84(8):762-3.

doi: 10.1212/WNL.0000000000001292. Epub 2015 Jan 23.

¹ From the Department of Radiology & Nuclear Medicine (F.B.), VU University Medical Centre, Amsterdam, the Netherlands; and the Translational Neuroradiology Unit (D.S.R.), National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD. f.barkhof@vumc.nl.
² From the Department of Radiology & Nuclear Medicine (F.B.), VU University Medical Centre, Amsterdam, the Netherlands; and the Translational Neuroradiology Unit (D.S.R.), National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD.

No abstract available

Comment on

Investigation of leptomeningeal enhancement in MS: a postcontrast FLAIR MRI study.
Eisele P, Griebe M, Szabo K, Wolf ME, Alonso A, Engelhardt B, Hennerici MG, Gass A. Eisele P, et al. Neurology. 2015 Feb 24;84(8):770-5. doi: 10.1212/WNL.0000000000001286. Epub 2015 Jan 23. Neurology. 2015. PMID: 25616480